Paper475369
In vitro of cefotaxime against cephalothin-resistant clinical isolates.
Van Landuyt HW and 1 other. Antimicrob Agents Chemother, 1979. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. In vitro of cefotaxime against cephalothin-resistant clinical isolates. Papers, record 475369. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475369
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Cephalosporins | Major topic |
| Cephalothin | Major topic |
| Enterobacteriaceae | Major topic |
| Drug Resistance, Microbial | |
| Haemophilus | |
| Pseudomonas |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 101128 | beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/101128 | PubMed |
| 2 | 413795 | Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study. | Infection | 1977 | https://conductscience.org/library/papers/413795 | PubMed |
| 3 | 308506 | Activity of HR 756 against Haemophilus influenzae, Bacteroides fragilis and Gram-negative rods. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/308506 | PubMed |
| 4 | 308505 | Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/308505 | PubMed |
| 5 | 984801 | Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984801 | PubMed |
| 6 | 4210609 | Antibiotic susceptibility of gram-negative bacilli isolated from blood cultures. Results of tests with 35 agents and strains from 169 patients at Boston City Hospital during 1972. | Am J Med | 1974 | https://conductscience.org/library/papers/4210609 | PubMed |
| 7 | 4546094 | Haemophilus influenzae type B resistant to ampicillin. A report of two cases. | JAMA | 1974 | https://conductscience.org/library/papers/4546094 | PubMed |
| 8 | 4840447 | Cefoxitin, a semisynthetic cephamycin antibiotic: susceptibility studies. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4840447 | PubMed |
| 9 | 4790616 | Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4790616 | PubMed |
| 10 | 1259407 | Cefuroxime, a new cephalosporin antibiotic: activity in vitro. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1259407 | PubMed |
| 11 | 938029 | In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/938029 | PubMed |
| 12 | 1137364 | Susceptibility of anaerobes to cefoxitin and other cephalosporins. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1137364 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6995096 | The cephalosporins: activity and clinical use. | Drugs | 1980 | https://conductscience.org/library/papers/6995096 | PubMed |
| 6313487 | Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application. | Graefes Arch Clin Exp Ophthalmol | 1983 | https://conductscience.org/library/papers/6313487 | PubMed |
| 6282202 | Clinical efficacy of cefotaxime in serious infections. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6282202 | PubMed |
| 6282198 | Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6282198 | PubMed |
| 6275784 | Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6275784 | PubMed |
| 6252832 | In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252832 | PubMed |
| 6252831 | Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6252831 | PubMed |
| 6251750 | Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6251750 | PubMed |
| 6251749 | In vitro antimicrobial activity of cefotaxime, a new cephalosporin. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6251749 | PubMed |
| 2073095 | Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime, cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli isolated from stools of children attending day-care centers. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2073095 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/475369
GET https://conductscience.org/api/papers/v1/475369/authors